The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

By sjmartinez • January 19, 2025

Packard RRS. The clinical promise of ¹⁸F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease. Nat Cardiovasc Res. 2025 Jan;4(1):1-4. doi: 10.1038/s44161-024-00587-w. PMID: 39825085.

Tags: Cardiology/Epi, Publications

Jay M. Patel, MD Appointed Medical Director of the Cardiac Catheterization Laboratory at UCLA West Valley Medical Center

We are pleased to announce that Jay M. Patel, MD, has been appointed medical director of the Cardiac Catheterization Laboratory at UCLA West Valley Medical[...]

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Hoffman R, Watanabe M, Martínez E, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Lu[...]

Lipids and lipoproteins in calcific aortic valve disease

Aksoy O, Tintut Y, Demer LL. Lipids and lipoproteins in calcific aortic valve disease. Curr Opin Lipidol. 2026 Oct 1;37(5):185-190. doi: 10.1097/MOL.0000000000001053. Epub 2026 Aug[...]